| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = -$124,053 ) |
| | 2022 | 2020 | PROFECTUS BIOSCIENCES, INC. | 401 N MIDDLETOWN RD # 205 | PEARL RIVER | NY | 10965-1298 | ROCKLAND | USA | R03AI141031 | Sonoporation as a novel delivery platform for an HIV DNA vaccine | 001 | 2 | NIH | 11/4/2021 | -$69,471 |
| | 2022 | 2020 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R03AI141031 | Sonoporation as a novel delivery platform for an HIV DNA vaccine | 004 | 2 | NIH | 2/22/2022 | $0 |
| | 2022 | 2020 | PROFECTUS BIOSCIENCES, INC. | 401 N MIDDLETOWN RD # 205 | PEARL RIVER | NY | 10965-1298 | ROCKLAND | USA | R03AI141031 | Sonoporation as a novel delivery platform for an HIV DNA vaccine | 003 | 2 | NIH | 2/15/2022 | -$54,528 |
| | 2022 | 2019 | PROFECTUS BIOSCIENCES, INC. | 401 N MIDDLETOWN RD # 205 | PEARL RIVER | NY | 10965-1298 | ROCKLAND | USA | R03AI141031 | Sonoporation as a novel delivery platform for an HIV DNA vaccine | 002 | 1 | NIH | 1/31/2022 | $69,538 |
| | 2022 | 2019 | PROFECTUS BIOSCIENCES, INC. | 401 N MIDDLETOWN RD # 205 | PEARL RIVER | NY | 10965-1298 | ROCKLAND | USA | R03AI141031 | Sonoporation as a novel delivery platform for an HIV DNA vaccine | 000 | 1 | NIH | 11/4/2021 | -$69,538 |
| | 2022 | 2018 | PROFECTUS BIOSCIENCES, INC. | 401 N MIDDLETOWN RD # 205 | PEARL RIVER | NY | 10965-1298 | ROCKLAND | USA | R44AI114331 | Optimization of an innate immune stimulating adjuvant for an HIV DNA vaccine | 001 | 2 | NIH | 9/23/2022 | $1,062 |
| | 2022 | 2017 | PROFECTUS BIOSCIENCES, INC. | 401 N MIDDLETOWN RD # 205 | PEARL RIVER | NY | 10965-1298 | ROCKLAND | USA | R43AI134225 | Therapeutic Vaccine for Walnut and Pecan Allergies | 000 | 1 | NIH | 9/26/2022 | $837 |
| | 2022 | 2016 | PROFECTUS BIOSCIENCES, INC. | 401 N MIDDLETOWN RD # 205 | PEARL RIVER | NY | 10965-1298 | ROCKLAND | USA | R43AI122371 | DNA Prime / Subunit Boost Multi-Antigen Universal Influenza Vaccine | 000 | 1 | NIH | 10/1/2021 | -$1,953 |
|
| Issue Date FY: 2020 ( Subtotal = -$141,352 ) |
| | 2020 | 2020 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R03AI141031 | Sonoporation as a novel delivery platform for an HIV DNA vaccine | 000 | 2 | NIH | 1/2/2020 | $69,471 |
| | 2020 | 2018 | PROFECTUS BIOSCIENCES, INC. | 401 N MIDDLETOWN RD # 205 | PEARL RIVER | NY | 10965-1298 | ROCKLAND | USA | R44AI114331 | Optimization of an innate immune stimulating adjuvant for an HIV DNA vaccine | 000 | 2 | NIH | 12/19/2019 | -$209,092 |
| | 2020 | 2017 | PROFECTUS BIOSCIENCES, INC. | 401 N MIDDLETOWN RD # 205 | PEARL RIVER | NY | 10965-1298 | ROCKLAND | USA | R44AI089290 | Novel Mucosal Adjuvant for an HIV DNA Vaccine | 000 | 3 | NIH | 12/9/2019 | -$104 |
| | 2020 | 2017 | PROFECTUS BIOSCIENCES, INC. | 401 N MIDDLETOWN RD # 205 | PEARL RIVER | NY | 10965-1298 | ROCKLAND | USA | R43AI134225 | Therapeutic Vaccine for Walnut and Pecan Allergies | 000 | 1 | NIH | 11/5/2019 | -$1,627 |
| | 2020 | 2016 | PROFECTUS BIOSCIENCES, INC. | 401 N MIDDLETOWN RD # 205 | PEARL RIVER | NY | 10965-1298 | ROCKLAND | USA | R01AI098817 | rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses | 000 | 5 | NIH | 11/5/2019 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = -$20,415 ) |
| | 2019 | 2019 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R44AI122371 | Development of a rapid response nucleic acid vaccine strategy for coronavirus epidemics | 000 | 2 | NIH | 4/23/2019 | $997,172 |
| | 2019 | 2019 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R03AI141031 | Sonoporation as a novel delivery platform for an HIV DNA vaccine | 001 | 1 | NIH | 8/6/2019 | $0 |
| | 2019 | 2019 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R44AI122371 | Development of a rapid response nucleic acid vaccine strategy for coronavirus epidemics | 001 | 2 | NIH | 8/16/2019 | -$997,172 |
| | 2019 | 2019 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R03AI141031 | Sonoporation as a novel delivery platform for an HIV DNA vaccine | 000 | 1 | NIH | 1/7/2019 | $69,538 |
| | 2019 | 2018 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R44AI114331 | Optimization of an innate immune stimulating adjuvant for an HIV DNA vaccine | 000 | 2 | NIH | 8/23/2019 | $0 |
| | 2019 | 2017 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R44AI110315 | Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine | 000 | 4 | NIH | 1/9/2019 | -$10,017 |
| | 2019 | 2016 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R43AI122371 | DNA Prime / Subunit Boost Multi-Antigen Universal Influenza Vaccine | 000 | 1 | NIH | 2/8/2019 | $0 |
| | 2019 | 2016 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R01AI098760 | Development of sG as a human vaccine against Nipah/Hendra | 000 | 5 | NIH | 5/21/2019 | -$79,094 |
| | 2019 | 2016 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R01AI098760 | Development of sG as a human vaccine against Nipah/Hendra | 001 | 5 | NIH | 5/21/2019 | $1 |
| | 2019 | 2016 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R44AI114319 | An HIV Vaccine Strategy Based on Priming with rVSV Expressing FLSC | 000 | 3 | NIH | 1/11/2019 | -$2 |
| | 2019 | 2015 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R44AI102702 | Optimization of a DNA Subunit Regimen for an HIV Vaccine | 000 | 4 | NIH | 6/24/2019 | $0 |
| | 2019 | 2015 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R01AI093346 | Preclinical Development of m102.4, a Human Anti-Hendra and Nipah Antibody | 000 | 5 | NIH | 9/24/2019 | -$841 |
|
| Issue Date FY: 2018 ( Subtotal = $993,161 ) |
| | 2018 | 2018 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R44AI114331 | Optimization of an innate immune stimulating adjuvant for an HIV DNA vaccine | 000 | 2 | NIH | 8/28/2018 | $993,161 |
| | 2018 | 2016 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R01AI098817 | rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses | 000 | 5 | NIH | 5/7/2018 | $0 |
| | 2018 | 2016 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R01AI098760 | Development of sG as a human vaccine against Nipah/Hendra | 000 | 5 | NIH | 2/5/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $1,873,290 ) |
| | 2017 | 2017 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R44AI110315 | Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine | 000 | 4 | NIH | 7/13/2017 | $838,478 |
| | 2017 | 2017 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R44AI089290 | Novel Mucosal Adjuvant for an HIV DNA Vaccine | 000 | 3 | NIH | 6/1/2017 | $733,632 |
| | 2017 | 2017 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R44AI089290 | Novel Mucosal Adjuvant for an HIV DNA Vaccine | 001 | 3 | NIH | 7/21/2017 | $59,716 |
| | 2017 | 2017 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R43AI134225 | Therapeutic Vaccine for Walnut and Pecan Allergies | 000 | 1 | NIH | 6/5/2017 | $241,464 |
| | 2017 | 2016 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R01AI098817 | rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses | 001 | 5 | NIH | 8/25/2017 | $472,566 |
| | 2017 | 2016 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R01AI098760 | Development of sG as a human vaccine against Nipah/Hendra | 001 | 5 | NIH | 8/26/2017 | $904,394 |
| | 2017 | 2015 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R01AI098760 | Development of sG as a human vaccine against Nipah/Hendra | 000 | 4 | NIH | 8/26/2017 | -$904,394 |
| | 2017 | 2015 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R01AI098817 | rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses | 000 | 4 | NIH | 8/25/2017 | -$472,566 |
| | 2017 | 2015 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R44AI102702 | Optimization of a DNA Subunit Regimen for an HIV Vaccine | 000 | 4 | NIH | 8/25/2017 | $0 |
| | 2017 | 2015 | PROFECTUS BIOSCIENCES, INC. | 6411 BECKLEY ST STE 201 | BALTIMORE | MD | 21224-6538 | BALTIMORE CITY | USA | R01AI093346 | Preclinical Development of m102.4, a Human Anti-Hendra and Nipah Antibody | 000 | 5 | NIH | 8/25/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $5,340,365 ) |
| | 2016 | 2016 | PROFECTUS BIOSCIENCES INC | 6411 BECKLEY STREET | BALTIMORE | MD | 21227-3869 | BALTIMORE | USA | R01AI098817 | rVSV Vectored Vaccine to Protect Against Ebola and Marburg Viruses | 000 | 5 | NIH | 4/25/2016 | $1,208,817 |
| | 2016 | 2016 | PROFECTUS BIOSCIENCES INC | 6411 BECKLEY STREET | BALTIMORE | MD | 21227-3869 | BALTIMORE | USA | R43AI122371 | DNA Prime / Subunit Boost Multi-Antigen Universal Influenza Vaccine | 000 | 1 | NIH | 6/14/2016 | $299,921 |
| | 2016 | 2016 | PROFECTUS BIOSCIENCES INC | 6411 BECKLEY STREET | BALTIMORE | MD | 21227-3869 | BALTIMORE | USA | R01AI098760 | Development of sG as a human vaccine against Nipah/Hendra | 000 | 5 | NIH | 4/25/2016 | $1,129,038 |
| | 2016 | 2016 | PROFECTUS BIOSCIENCES INC | 6411 BECKLEY STREET | BALTIMORE | MD | 21227-3869 | BALTIMORE | USA | R44AI110315 | Optimization of a Therapeutic HIVSIV Multi-Antigen DNA Vaccine | 000 | 3 | NIH | 7/21/2016 | $968,957 |
| | 2016 | 2016 | PROFECTUS BIOSCIENCES INC | 6411 BECKLEY STREET | BALTIMORE | MD | 21227-3869 | BALTIMORE | USA | R44AI114319 | An HIV Vaccine Strategy Based on Priming with rVSV Expressing FLSC | 000 | 3 | NIH | 7/14/2016 | $1,000,000 |
| | 2016 | 2016 | PROFECTUS BIOSCIENCES INC | 6411 BECKLEY STREET | BALTIMORE | MD | 21227-3869 | BALTIMORE | USA | R44AI089290 | Novel Mucosal Adjuvant for an HIV DNA Vaccine | 000 | 2 | NIH | 6/29/2016 | $733,632 |
|
|
